Abdominal Fat Poses Higher Risk Than Overall Obesity In India; Says Dr Jitendra Singh
Dr Jitendra Singh warns that abdominal fat drives higher health risks in Indians, urging early detection, a balanced lifestyle, and scientific preventive care.
Early Detection Of Lung Cancer Can Save Lives, Say Experts
An expert doctor urges timely attention to subtle early signs of lung cancer, including cough, weight loss, and breathlessness.
Immunotherapy Explained: How The Immune System Is Being Used To Fight Cancer
Immunotherapy boosts the immune system to fight cancer, offering durable responses with fewer side effects, though not all patients benefit equally.
New Study Reveals Brain Pathway Behind Metformin’s Blood Sugar Control
A new study reveals how Metformin lowers blood sugar through a brain pathway involving Rap1, opening avenues for targeted diabetes therapies.
Can This Indian Brain Study Change Mental Healthcare? Inside The CALM-Brain Project
Can India’s CALM-Brain project transform mental healthcare? The study tracks brain, genetic and behavioural data to improve diagnosis and treatment.
Is Antibiotic-Resistant Typhoid Costing India More Than We Think?
Is antibiotic-resistant typhoid increasing India’s health burden? A new study highlights rising costs, impact on children, and urgent need for vaccination.
Indonesia Intensifies TB Control Efforts With New Strategic Plan
Indonesia ramps up efforts to tackle tuberculosis, targeting 1 million cases with new reforms, digital tracking and vaccine development plans.
India Commits To TB-Free Nation With 100‑Day National Campaign & New Digital Tools
The government will launch a 100‑day campaign from March 24 to boost TB elimination through TB Mukt Bharat Abhiyaan.
Gorakhpur Mayor Backs Cycle Rally To Improve Childhood Cancer Care In UP
Gorakhpur Mayor supports Cycle for Gold rally, promotes awareness, early diagnosis, and improved childhood cancer treatment facilities across Uttar Pradesh.
Indian Pharma Firms Introduce Generic Semaglutide Injections For Diabetes & Obesity Treatment
Indian drugmakers launch affordable semaglutide injections after patent expiry, expanding access for diabetes and obesity patients across the country.
